USPTO 2015–2025 USPTO PatentsView US Corporation

TRANSLATE BIO, INC.

USPTO PatentsView assignee record — 132 granted patents across 22 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

132
Total patents granted
22
CPC technology areas
16.1
Avg claims per patent
+177%
5-year filing velocity

Portfolio overview

TRANSLATE BIO, INC. has been granted 132 US utility patents between 2017 and 2025, placing TRANSLATE BIO, INC. at rank #2,904 across all assignees tracked by PlainPatent. This portfolio spans 22 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.1 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a US Corporation, TRANSLATE BIO, INC. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 49.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 97 grants, compared with 35 in the 2015–2019 window — a +177% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. TRANSLATE BIO, INC.'s 16.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 22 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark TRANSLATE BIO, INC. against peers pursuing similar technology classes.

How does TRANSLATE compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows TRANSLATE holds 132 patents — placing it at rank #2,904 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2017–2025

-50510152025 201720182019202020212022202320242025 15
USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
TRANSLATE BIO, INC. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 1 0.8%
2018 16 12.1%
2019 18 13.6%
2020 14 10.6%
2021 21 15.9%
2022 16 12.1%
2023 8 6.1%
2024 23 17.4%
2025 15 11.4%

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Accelerating

Where it ranks

Overall rank by patents

#2,904

Across all tracked assignees

Innovation Score

49.0 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does TRANSLATE BIO, INC. hold?
TRANSLATE BIO, INC. holds 132 US granted patents filed between 2017 and 2025, spanning 22 technology areas.
What is TRANSLATE BIO, INC.'s Innovation Score?
TRANSLATE BIO, INC. has an Innovation Score of 49.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does TRANSLATE BIO, INC. focus on?
TRANSLATE BIO, INC.'s top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 103 patents. The company has filed patents in 22 CPC subclasses total.
Is TRANSLATE BIO, INC.'s patent filing rate increasing or decreasing?
TRANSLATE BIO, INC.'s recent filing velocity is +177% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for TRANSLATE BIO, INC.'s patents?
TRANSLATE BIO, INC.'s patents average 16.1 claims each. This falls within the standard range, providing solid legal coverage.
How is the TRANSLATE BIO, INC. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope